143 related articles for article (PubMed ID: 10673512)
21. Long-term clinical outcome of AIDS-related Kaposi's sarcoma during highly active antiretroviral therapy.
Cattelan AM; Calabrò ML; De Rossi A; Aversa SM; Barbierato M; Trevenzoli M; Gasperini P; Zanchetta M; Cadrobbi P; Monfardini S; Chieco-Bianchi L
Int J Oncol; 2005 Sep; 27(3):779-85. PubMed ID: 16077928
[TBL] [Abstract][Full Text] [Related]
22. Recent advances in the treatment of AIDS-related Kaposi's sarcoma.
Cattelan AM; Trevenzoli M; Aversa SM
Am J Clin Dermatol; 2002; 3(7):451-62. PubMed ID: 12180893
[TBL] [Abstract][Full Text] [Related]
23. Weekly docetaxel is safe and effective in the treatment of advanced-stage acquired immunodeficiency syndrome-related Kaposi sarcoma.
Lim ST; Tupule A; Espina BM; Levine AM
Cancer; 2005 Jan; 103(2):417-21. PubMed ID: 15578686
[TBL] [Abstract][Full Text] [Related]
24. Interferon-alpha2b with protease inhibitor-based antiretroviral therapy in patients with AIDS-associated Kaposi sarcoma: an AIDS malignancy consortium phase I trial.
Krown SE; Lee JY; Lin L; Fischl MA; Ambinder R; Von Roenn JH
J Acquir Immune Defic Syndr; 2006 Feb; 41(2):149-53. PubMed ID: 16394845
[TBL] [Abstract][Full Text] [Related]
25. Fractionated doses of oral etoposide in the treatment of patients with aids-related kaposi sarcoma: a clinical and pharmacologic study to improve therapeutic index.
Sprinz E; Caldas AP; Mans DR; Cancela A; DiLeone L; Dalla Costa T; Schwartsmann G
Am J Clin Oncol; 2001 Apr; 24(2):177-84. PubMed ID: 11319295
[TBL] [Abstract][Full Text] [Related]
26. [Monotherapy of endemic Kaposi sarcoma with long-term vincristine infusion].
Haubenstock A; Malamud SC; Pipala JH; Mernick MH; DeVries K; Base W; Zalusky R
Wien Klin Wochenschr; 1987 Apr; 99(7):239-42. PubMed ID: 3590803
[TBL] [Abstract][Full Text] [Related]
27. Pulmonary Kaposi's sarcoma in AIDS patients treated with combined chemotherapy and recombinant human granulocyte colony-stimulating factor.
Mastroianni A; Coronado O; Cancellieri C; Manfredi R; Pignatari S; Chiodo F
J Chemother; 1998 Oct; 10(5):405-10. PubMed ID: 9822360
[TBL] [Abstract][Full Text] [Related]
28. A retrospective analysis of thalidomide therapy in non-HIV-related Kaposi's sarcoma.
Ben M'barek L; Fardet L; Mebazaa A; Thervet E; Biet I; Kérob D; Morel P; Lebbe C
Dermatology; 2007; 215(3):202-5. PubMed ID: 17823515
[TBL] [Abstract][Full Text] [Related]
29. AIDS-related Kaposi's sarcoma: a phase II study of liposomal doxorubicin. The TLC D-99 Study Group.
Cheung TW; Remick SC; Azarnia N; Proper JA; Barrueco JR; Dezube BJ
Clin Cancer Res; 1999 Nov; 5(11):3432-7. PubMed ID: 10589755
[TBL] [Abstract][Full Text] [Related]
30. Phase II trial of liposomal daunorubicin in the treatment of AIDS-related pulmonary Kaposi's sarcoma.
Tulpule A; Yung RC; Wernz J; Espina BM; Myers A; Scadden DT; Cabriales S; Ilaw M; Boswell W; Gill PS
J Clin Oncol; 1998 Oct; 16(10):3369-74. PubMed ID: 9779714
[TBL] [Abstract][Full Text] [Related]
31. Treatment of Kaposi's sarcoma--an update.
Toschi E; Sgadari C; Monini P; Barillari G; Bacigalupo I; Palladino C; Baccarini S; Carlei D; Grosso G; Sirianni MC; Ensoli B
Anticancer Drugs; 2002 Nov; 13(10):977-87. PubMed ID: 12439331
[TBL] [Abstract][Full Text] [Related]
32. Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin.
Gill PS; Espina BM; Muggia F; Cabriales S; Tulpule A; Esplin JA; Liebman HA; Forssen E; Ross ME; Levine AM
J Clin Oncol; 1995 Apr; 13(4):996-1003. PubMed ID: 7707129
[TBL] [Abstract][Full Text] [Related]
33. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
[TBL] [Abstract][Full Text] [Related]
34. Phase III vehicle-controlled, multi-centered study of topical alitretinoin gel 0.1% in cutaneous AIDS-related Kaposi's sarcoma.
Bodsworth NJ; Bloch M; Bower M; Donnell D; Yocum R;
Am J Clin Dermatol; 2001; 2(2):77-87. PubMed ID: 11705307
[TBL] [Abstract][Full Text] [Related]
35. Pegylated liposomal doxorubicin as first line treatment in aids-related Kaposi's sarcoma: a real-life study.
Dalu D; Fasola C; Ammoni L; De Francesco D; Cona MS; Rota S; Ferrario S; Gambaro A; Tosca N; Piva S; La Verde N
J Chemother; 2021 Sep; 33(5):342-347. PubMed ID: 34060438
[TBL] [Abstract][Full Text] [Related]
36. Phase II study of liposomal encapsulated daunorubicin in the treatment of AIDS-associated mucocutaneous Kaposi's sarcoma.
Girard PM; Bouchaud O; Goetschel A; Mukwaya G; Eestermans G; Ross M; Rozenbaum W; Saimot AG
AIDS; 1996 Jun; 10(7):753-7. PubMed ID: 8805866
[TBL] [Abstract][Full Text] [Related]
37. AIDS-related Kaposi's sarcoma cells rapidly internalize endostatin, which co-localizes to tropomysin microfilaments and inhibits cytokine-mediated migration and invasion.
Mallery SR; Morse MA; Wilson RF; Pei P; Ness GM; Bradburn JE; Renner RJ; Schuller DE; Robertson FM
J Cell Biochem; 2003 May; 89(1):133-43. PubMed ID: 12682914
[TBL] [Abstract][Full Text] [Related]
38. Regression of AIDS-related Kaposi's sarcoma following combined antiretroviral treatment.
Monticelli A; Lewi D; Salomon H; Pampuro S; Libonatti O; Jauregui Rueda H; Hodara V
Rev Argent Microbiol; 2000; 32(4):206-8. PubMed ID: 11149154
[TBL] [Abstract][Full Text] [Related]
39. Vinorelbine is an effective and safe drug for AIDS-related Kaposi's sarcoma: results of a phase II study.
Nasti G; Errante D; Talamini R; Rizzardini G; Fasan M; Landonio G; Zeroli C; Chichino G; Nigra E; Vaccher E; Tirelli U
J Clin Oncol; 2000 Apr; 18(7):1550-7. PubMed ID: 10735904
[TBL] [Abstract][Full Text] [Related]
40. Kaposi's sarcoma: a reevaluation.
Orfanos CE; Husak R; Wölfer U; Garbe C
Recent Results Cancer Res; 1995; 139():275-96. PubMed ID: 7541146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]